Clinical Trial Update: Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001 [Phase 2, Phase 3]

View source ↗

Summary

DIAN-TU-001 is a master protocol investigating potential disease-modifying treatments for dominantly inherited Alzheimer's disease in individuals at risk for or…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Alzheimer Disease Familial
• Dementia

Snippet

Sponsor: Washington University School of Medicine | Conditions: Alzheimers Disease, Dementia | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING